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Abstract 
A number of new [(pyrazol-4-yl) methylene] hydrazono-2,3-dihydrothiazoles, sugar hydrazones, and their N-
glycoside derivatives were synthesized. The chemical structures of the synthesized compounds were confirmed 
by 
1
H NMR technique. The newly synthesized compounds were tested for their antimicrobial activities and 
showed moderate to high inhibition activities. Quantum chemistry calculations were used to study the molecular 
geometry and electronic structure of the selected derivatives. The energy gap between the highest occupied 
molecular orbital (HOMO)and lowest unoccupied molecular orbital (LUMO) has been calculated using the 
theoretical computations to reflect the chemical reactivity and kinetic stability of compounds. 
Keywords: 1H-pyrazole, aminothiazole, ethylchloroacetate, quantum chemical calculations, antimicrobial 
activity.  
 
1. Introduction  
The chemistry of 1H-pyrazole-containing compounds is particularly interesting because oftheir potential 
application in medicinal chemistry as analgesic [Wise, et al 1987, Gursoy et al 2000], anti-inflammatory [Tsuji et 
al 1997, Badawey et al,1998], antitumor [Daidone et al 1998, Hilgard et al 1992], antimicrobial [Prasath  et al 
2015, Nauduri  et al 1998, Foks  et al 2005, Dardari  et al 2006, Gilbert  et al 2006] and therapeutic agents [Jiang 
et al 1990], as well as based on their wide applications in agriculture as potent insecticides [Parlok,1998] and 
herbicides [Frinkelstein et al,1997, Schallner et al 1997], although scarcely found in nature [Eicher et al 1995]. 
Due to many promising pharmacological, agrochemical, and analytical applications, a number of substituted 
pyrazoles are being used as inhibitors of heat-shock protein 90 (HSP90) and as therapeutics of cancer 
andtherefore they have been the focus of many synthetic targets over the past decades [Jolly et al 
2000].Furthermore, it has also been found that 1H-pyrazolebased heterocyclic structures haveattracted synthetic 
interest for being an essential moieties in many chemotherapeutic agents with potential antiparasitic[Rathelot et 
al 2000, Bernardino et al 2006], antimalarial[Katiyar et al 2005] and antiviral activities [Moukha et al 2002, 
Allen et al 2006].As far as the anticancer activity is concerned, literature citation revealed that a wide range of 
pyrazole derivatives were reported to contribute to a variety of antineoplastic potentials against a wide range of 
cancer cell lines [Baraldi et al 2004, Daidone  et al 2004, Gopalsamy  et al 2004,- Cocco et al 2006]. Moreover, 
many pyrazole derivatives are associated with antifungal, antibacterial [Rebecca et al 2012] and antipyretic 
[Tsurumi et al 1978] properties. On the other hand, thiazole derivatives are considered as one of the most 
important classes of heterocyclic compounds; their derivatives are characterized with high biological activity in 
pharmaceutical fields and have showed antibacterial, antifungal, antitumer, antiviral, anti-inflammatory and 
antineoplastic activities as well as inhibitory activity of growth of gastrointestinal[Mirjana et al 2014, Wang  et 
al 2014], biliary and pancreatic adenocarcinoma cells. The aminothiazole ring system has found application in 
drug development for the treatment of HIV-infection, hypertension and inflammation.In view of the above 
findings and our interest in the attachment of sugar moieties to newly synthesized heterocycles[Abdel-Rahman  
et al 2008, El-Sayed  et al 2009, El-Sayed et al 2008] we report in the present work the synthesis of new 
substituted [(pyrazol-4-yl)methylene]hydrazono-2,3-dihydrothiazole derivatives and their substituted sugar 
derivatives. 
 
2. Experimental 
2.1 Synthesis of organic compounds  
The used organic compounds were prepared previously [Abdel-Rahman et al 2012]. The chemical structures 
were showed in Scheme 1. 
 
2.2 Analysis  
Melting points were determined using a Büchi apparatus. IR spectra (KBr) were recorded with a Bruker-
Vector22 instrument (Bruker, Bremen, Germany). 
1
H NMR spectra were recorded with a Varian Gemini 
spectrometer at 300 MHz and 200 MHz with TMS as internal standard. Chemical shifts were reported in δ scale 
(ppm) relative to TMS as a standard, and the coupling constants (J values) are given in Hz. The microanalyses 
were performed at the micro analytical unit, Tokyo University, Japan. The progress of the reactions was 
monitored by TLC using aluminum silica gel plates 60 F245. EI-mass spectra were recorded with a HP D5988 A 
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1000 MHz instrument (Hewlett-Packard, Palo Alto, CA, USA).  
 
2.3 Culture ofmicroorganisms 
Bacteria strains were supplied from Botany Department, Faculty of Science, Menoufia University, Shebin El-
Koam, Egypt, namely Bacillus subtilis (ATCC 6633) (Gram-positive), Pseudomonas aeruginosa(ATCC 27853) 
(Gram-negative) and Streptomyces species (Actinomycetes). The bacterial strains were maintained on MHA 
(Mueller – Hinton agar) medium (Oxoid, Chemical Co., UK) for 24 h at 37 °C. The medium was molten on a 
water bath, inoculated with 0.5 ml of the culture of the specific microorganism and poured into sterile Petri 
dishes to form a layer of about 3-4 mm thickness. The layer was allowed to cool and harden. With the aid of 
cork-borer, cups of about 10 mm diameter were produced [Janssen et al 1987] 
 
2.4 Agar diffusion technique 
The antibacterial activies of the synthesized compounds were tested against Bacillus subtilis (ATCC 6633) 
(Gram-positive), Pseudomonas aeruginosa(ATCC 27853) (Gram-negative) and Streptomyces species 
(Actinomycetes) using MH medium ( 17.5 g casein hydrolysate , 1.5 g soluble starch, 1000 ml beef extract ).  A 
stock solution of each synthesized compound (500 µg/mL) in DMSO was prepared and graded quantities of the 
test compounds were incorporated in specified quantity of sterilized liquid MH medium.  Different 
concentrations of the test compounds in DMF were placed separately in cups in the agar medium. All plates were 
incubated at 37 ºC overnight. The inhibition zones were measured after 24 h. The minimum inhibitory 
concentration (MIC) was defined as the intercept of the graveof logarithm concentrations versus diameter of the 
inhibition zones[Jorgensen et al 1999, Greenwood et al 2000]. 
 
2.5 Quantum chemical study 
All required molecular parameters were carried out based on MINDO3 semi-empirical method ever used for 
organic compound calculation [Shuduan et al 2012] at an Unrestricted HartreeFock (UHF) level which are 
implemented in Hyperchem 8.0. The molecule 2D sketch was obtained by ISIS Draw 2.1.4. 
 
3. Results and discussion  
3.1 Synthesis of 2-{[[3-(Biphenyl-4-yl)-1-phenyl-1H-pyrazol-4-yl]methylene]hydrazono}-4-phenyl-2,3-
dihydrothiazole (I).  
Yellow solid (3.87 g, 78%), mp 197-198 ºC; IR (KBr) ν 3316 (NH), 1610 cm
-1
 (C=N); 
1
H NMR (DMSO-d6) δ: 
5.86 (1H, s, thiazole H-5),7.19 (2H, d, J = 8.5 Hz, Ar-H), 7.51 (4H, m, Ar-H), 7.58 (1H, s, CH=N), 7.64 (4H, m, 
Ar-H, pyrazole H-3), 7.70 (2H, d, J = 8.5 Hz,  Ar-H), 7.79 (2H, m, Ar-H), 7.86 (4H, m, Ar-H), 7.96 (2H, d, J = 
8.2 Hz, Ar-H), 9.82 (1H, s, NH); MS m/z (%): 497 (M
+
, 12). Anal.Calcd.for C31H23N5S: C, 74.82; H, 4.66; N, 
14.07. Found: C, 74.63; H, 4.49; N, 13.85%. 
 
3.2 Synthesis of 2-{2-[2-[[[3-(Biphenyl-3-yl)-1-phenyl-1H-pyrazol-4-yl]methylene]-hydrazono]-4-
phenylthiazol-3(2H)-yl]ethoxy}ethanol (II). IR (KBr) ν 3426 (OH), 1612 cm
-1
 (C=N); 
1
H NMR (DMSO-d6) 
δ:3.96 (2H, t, J = 6.2 Hz, CH2), 4.12 (2H,t, J = 6.6 Hz, CH2), 4.25 (2H, t, J = 6.2 Hz, CH2), 4.74 (2H,t, J = 6.6 
Hz, CH2), 5.89 (1H, s, thiazole H-5),7.20 (2H, d, J = 8.5 Hz, Ar-H), 7.51 (4H, m, Ar-H), 7.57 (1H, s, CH=N), 
7.65 (4H, m, Ar-H,pyrazole H-3), 7.70 (2H, d, J = 8.5 Hz,Ar-H), 7.83 (2H, m, Ar-H), 7.86 (4H, m, Ar-H), 7.99 
(2H,d, J = 8.2 Hz, Ar-H); MS m/z (%): 585 (M
+
, 10). Anal.Calcd.for C35H31N5O2S: C, 71.77; H, 5.33; N, 11.96. 
Found: C, 71.50; H, 5.19; N, 11.74%. 
 
3.3. Synthesis of 2-{[[3-(Biphenyl-3-yl)-1-phenyl-1H-pyrazol-4-yl]methylene]hydrazono}-3-(ß-D-
glucopyranosyl)-4-phenyl-2,3-dihydrothiazole (III). Yellow solid (5.93 g, 91%), mp196-197 ºC; IR (KBr) ν 
3398 (OH), 1612 cm
-1
 (C=N); 
1
H NMR (DMSO-d6) δ:3.88 (2H, m, H-6,6′), 4.15 (2H, m, H-4,5), 4.47 (2H, s, 
CH2), 4.24 (2H, m, H-2,3), 5.74 (1H, d, J= 9.8 Hz, H-1), 5.88 (1H, s, thiazole H-5),7.19 (2H, d, J = 8.5 Hz, Ar-
H), 7.51 (4H,m, Ar-H), 7.59 (1H, s, CH=N), 7.65 (4H,m, Ar-H,pyrazole H-3), 7.71 (2H, d, J = 8.5 Hz, Ar-H), 
7.80 (2H,m, Ar-H), 7.87(4H, m, Ar-H), 7.98 (2H, d, J = 8.2 Hz, Ar-H); MS m/z (%) 659 (M
+
, 12). 
Anal.Calcd.for C37H33N5O5S: C, 67.36; H, 5.04; N, 10.62. Found: C, 67.05; H, 4.91; N, 10.31%. 
 
3.4. D-Xylose 2-{2-[[(3-(biphenyl-3-yl)-1-phenyl-1H-pyrazol-4-yl]methylene)-hydrazono]-4-phenylthiazol-
3(2H)-yl}acetohydrazone(IV). 
Yellow solid (5.74 g, 82%), mp 203-205 ºC; IR (KBr) ν 3412 (OH), 1664 (C=O), 1614 cm
-1
 (C=N); 
1
H NMR 
(DMSO-d6) δ:3.64 (2H, m, H-5,5′), 4.18 (2H, m, H-4), 4.23 (2H, m, H-2,3), 5.16 (2H, s, CH2), 5.88 (1H, s, 
thiazole H-5),7.25 (2H, d, J = 8.5 Hz, Ar-H), 7.55 (4H,m, Ar-H), 7.59 (1H, s, CH=N), 7.69 (4H, m, Ar-H, 
pyrazole H-3), 7.75 (2H, d, J = 8.5 Hz, Ar-H), 7.79 (2H,m, Ar-H), 7.86 (4H, m, Ar-H), 7.98 (2H,d, J = 8.2 Hz, 
Ar-H), 10.22 (1H, s, NH); MS m/z (%): 701 (M
+
, 10). Anal.Calcd.for C38H35N7O5S: C, 65.03; H, 5.03; N, 13.97. 
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Found: C, 64.96; H, 4.94; N, 13.72% 
 
3.5 Antimicrobial activity 
The synthesized compounds were tested for their antimicrobial activity against three microorganisms and the 
minimal inhibitory concentrations (MICs) of the tested compounds were determined by the dilution method. 
Each of the test compounds and standards were dissolved in 12.5% DMSO, at concentrations of 500 µg/mL. 
Further dilutions of the compounds and standards in the test medium were prepared at the required quantities. 
 Bacteria strains were supplied from Botany Department, Faculty of Science, Menoufia University, 
Shebin El-Koam, Egypt, namely Bacillus subtilis (ATCC 6633) (Gram-positive), Pseudomonas 
aeruginosa(ATCC 27853) (Gram-negative) and Streptomycesspecies (Actinomycetes). The bacterial strains 
were maintained on MHA (Mueller – Hinton agar) medium (Oxoid, Chemical Co., UK) for 24 h at 37 °C. The 
medium was molten on a water bath, inoculated with 0.5 ml of the culture of the specific microorganism and 
poured into sterile Petri dishes to form a layer of about 3-4 mm thickness. The layer was allowed to cool and 
harden.  
The antimicrobial activity of the synthesized compounds was evaluated against three microorganisms; 
Bacillus subtilis(ATCC 6633) (Gram-positive), Pseudomonas aeruginosa (ATCC 27853) (Gram-negative), and 
Streptomyces species (Actinomycetes). The values of minimal inhibitory concentrations (MICs) of the tested 
compounds are presented in Table I. The results of the antimicrobial activity test revealed that I, II, III and IV 
showed the highest activity against B. subtilis with MIC values of 75 µg/mL Compounds III showed the highest 
inhibition activity against P.aeruginosa, whereas I and III and IV were the most active among the series of 
tested compounds against Streptomyces species with MIC values of 75 µg/mL. Fig. 1The results also revealed 
that some compounds showed little or no activity against the microorganisms (Table 1).  
From the structure-activity relationship it is clear that the N-substituted derivative of [(pyrazol-4-
yl)methylene]hydrazono-2,3-dihydrothiazole with free OH group as well as the free hydroxyl glycoside showed 
the highest activity against both B. subtilis and Streptomyces species. Furthermore, substitution at the p-position 
in the phenyl ring with chlorine atom increases its activity against the three microorganisms with respect to the 
corresponding trimethoxy derivatives. It is also clear that the free sugar hydrazones derived from pentose sugar 
moiety displayed higher activity than the corresponding hexoses sugars. In addition, the N-substituted acyclic 
nucleoside analogue II exhibited higher activity against Pseudomonas aeruginosa and Bacillus subtilis . 
 
3.6 Quantum chemical calculations 
The highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) play an 
important role in the molecule. These orbitals are sometimes referred to as the frontier molecular orbital.Fig. 2 
shows the frontier molecule orbital density distributions of investigated compounds The HOMO orbital is an 
electron donor and the LUMO orbital is the electron acceptor. The difference in energy between HOMO orbital 
and LUMO orbital (energy gap) is a very effective property for characterizing the kinetic stability and chemical 
reactivity of the molecules. A molecule with a small LUMO-HOMO energy gap is chemically more reactive and 
kinetically less stable. On the contrary, a large LUMO - HOMO energy gap corresponds to high kinetic stability 
and low chemical reactivity [Deepika et al 2015]. As shown in Tables 2, the result of theoretical calculations 
using (MINDO3) method reveals that in the case of the compound I, the energy of highest occupied molecular 
orbital (EHOMO) is -6.01eV, and the energy of the lowest unoccupied molecular orbital (ELUMO) is 0.430eV. 
Then, the frontier orbital gap in the compound I isabout 6.47eV. For the compound III, the energy of HOMO 
orbital (EHOMO) is -5.528eV, and the energy of the LUMO orbital (ELUMO) is 0.06 eV. Thus, the frontier 
orbital gap in the compound III is about 5.58eV. As a result, the compound III has more kinetic stability and less 
chemical reactivity than others, whereas the compound I has less kinetic stability and more chemical reactivity 
than others. 
The linkage between the molecular structures of compounds with its respective biological activities is 
central to the QSAR paradigm[Rav 2015]. Molecular descriptors play a crucial role in providing numerical 
description of the physicochemical properties of molecules. In order to properly account for these structural 
features, it is essential that suitable descriptors be chosen for QSAR investigation.  
µ refers to the dipole moment and it essentially provides a measure of the asymmetric distribution of 
charges in a molecule. It can be seen that compounds with the highest dipole moment were compounds IV > II > 
III > I with values respectively. It was observed that compounds IV bearing the carbonyl and more double bond 
in nitrogen in addition to the presence of the pentose sugar also had high dipole moment when compared to 
hetero rings. Such high value is associated with the asymmetric distribution of electrons as afforded by the 
strong electron withdrawing nature of pyrazole ant thiazole. 
A LogP provides a measure of a molecule’s lipophilicity where high ALogP value indicates high 
lipophilicity while low value suggests low lipophilicity[Ana et al 2014]. The results indicated that compounds 
having the highest lipophilicity were I > IV > II > III with corresponding values of 7.03, 6.89, 6.27 and 5.79, 
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respectively. The former two sets of molecules possessed the highest 
lipophilicity namely because of the presence of more rings at the N position of pyrazole and thiazole .  
 
3.7 Molecular electrostatic potential (MEP) 
The molecular electrostatic potential (MEP) was investigated by theoretical calculations at the MINDO3 (d, p) 
level. Molecular electrostatic potential is related to the electronic density and is a very useful descriptor in 
understanding sites for electrophilic attack and nucleophilic reactions as well as hydrogen bonding interactions 
[Scrocco  et al 1978, Luque  et al 2000, Okulik et al 2005]. Fig.3 shows the Molecular electrostatic potential map 
of the investigated compounds. The negative (redcolor) regions of MEP were related to electrophilic reactivity 
and the positive (green color) ones to nucleophilic reactivity shown in Fig. 3.As can be seen in from the figure, 
that oxygen of thiazole, hydroxyl group in the sugar and nitrogen atoms embedded in Pyrazol structure were 
thought to be the effective part of these heterocyclic compounds.  
 
4. Conclusion  
New [(pyrazol-4-yl)methylene]hydrazono-2,3-dihydrothiazole , their sugar hydrazones and N-substituted 
derivatives were synthesized and their chemical compositions were confirmed and their antibacterial activities 
were tested. The obtained results showed that some of them exhibited moderate to high antimicrobial activity 
against Bacillus subtilis, Pseudomonas aeruginosa, Streptomyces species (Actinomycetes) . Sugar hydrazones 
with free hydroxyl pentose sugar showed higher activities . Substitution of the thiazole with acyclic oxegented 
hydroxyl alkyl chain enhances antimicrobial activity. Both experimental techniques and theoretical methods 
were used to determine thestructural and spectroscopic properties of compound were in good result of each other. 
 
5. References 
Adel A.-H. Abdel-Rahman, Wael A. El-Sayed, El-Sayed G. Zaki ,Asem A. Mohamed , Ahmed A. Fadda (2012), 
Synthesis and antimicrobial activity of substituted [(pyrazol-4-yl)methylene]hydrazono-2,3-
dihydrothiazoles and their sugar derivatives Journal of Heterocyclic Chemistry,  49,  93–101 . 
Allen, S. H., Johns, B. A., Gudmundsson ,K. S., Freeman ,G. A.,(2006) Synthesis of C-6 substituted 
pyrazolo[1,5-a]pyridines with potent activity against herpesviruses 
 Bioorg. Med. Chem., 14, 944 . 
 Ana L.R. Silva , Victor M.F. Morais, Maria D.M.C. Ribeiro da Silva,(2014) Structural and energetic 
characterization of the tautomers2-benzothiazolinone and 2-hydroxybenzothiazoleJournal of Molecular 
Structure 1078 ,197–206. 
Abdel-Rahman ,A. A.-H., W. A. El-Sayed, H. M. Abdel-Bary, A. E.-S Abdel-Megied, E. M. Morcy,(2008) 
Amino acid derivatives, VIII [1]: Synthesis and antimicrobial evaluation of α-amino acid esters 
bearing an indole side chain Monatsh. Chem.139, 1095 . 
 Badawey ,A. M., El-Ashmawey, I. M., Eur. J. Med. Chem., 33, 349 (1998). 
 Baraldi, P. G., Beria, I., Cozzi, P., Geroni ,(2004) Synthesis of C-6 substituted pyrazolo[1,5-a]pyridines with 
potent activity against herpesviruses C.,Bioorg. Med. Chem., 12, 3911. 
Bernardino ,A. M. R., Gomes ,A. O., Charret, K. S., Freitas, A. C. C.,(2006) Synthesis and leishmanicidal 
activities of 1-(4-X-phenyl)-N′-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazidesEur. J. Med. 
Chem., 41, 80 . 
Cocco, M. T., Congiu ,C., Lilliu, V., Onnis ,V., Arch. Pharm. Chem. Life Sci., 339, 7 (2006). 
Deepika Gautam, Chaudhary ,R.P., Journal of Molecular Structure 1080 (2015) 137–144. 
Daidone ,G., Maggio ,B., Plescia, S., Raffa ,D., Musiu , Milia ,C., C., Perra ,G., Marongiu ,(1998) Antimicrobial 
and antineoplastic activities of new 4-diazopyrazole derivatives ,M. E., Eur. J. Med. Chem., 33, 375 . 
Dardari ,Z., Lemrani , Sebban,M., Bahloul ,A. A.,(2006) Antileishmanial and Antibacterial Activity of a New 
Pyrazole Derivative Designated 4-[2-(1-(Ethylamino)-2-methyl-propyl)phenyl]-3-(4-methyphenyl)-1-
henylpyrazole,Arch. Pharm. Chem. Life Sci., 33, 291 . 
Daidone,G. D. Raffa, Maggio, B., Raimondi ,M. V., Eur. J. Med. Chem. 39, 219 (2004),. 
Eicher, T., S. Hauptmann, SThe Chemistry of Heterocycles: Structure, Reactivity, Syntheses and Applications", 
Thieme-Verlag, New York, p. 184 (1995). 
El-Sayed, W. A., Nassar , Abdel-Rahman ,I. F., ,A. A.-H., C-Furyl glycosides, 2009II:Synthesis and 
antimicrobial evaluation of C-furyl glycosides bearing pyrazolines, isoxazolines, and 5,6-
dihydropyrimidine-2(1H)- thionesMonatsh.Chem., 140, 365 . 
El-Sayed ,W. A., Ramiz ,M. M. M., , Abdel-Rahman ,A. A.-H.,(2008) C-Furyl glycosides, I: Synthesis and 
antimicrobial evaluation of C-furyl glycosides and chalcones derived therefromMonatsh.Chem., 139, 
1499 . 
E. C. Taylor, H. Patel, H. Kumar, (1992)Synthesis of pyrazolo 3,4- pyrimidine analogues of the potent agent 
N-4-2-2-amino-4 3 -oxo-7 -pyrrolo 2,3- pyrimidin-5-yl ethylbenzoyl-L-glutamic acid 
Chemistry and Materials Research                                                                                                                                                    www.iiste.org 
ISSN 2224- 3224 (Print) ISSN 2225- 0956 (Online) 
Vol.6 No.12, 2014 
 
50 
(LY231514) Tetrahedron, 48, 8089 . 
Foks ,H., Pancechowska-Ksepko ,D., Kedzia ,A., Zwolska, Z., Farmaco, 60, 513 (2005). 
Frinkelstein ,B. L., . Strok ,C. J, Pestic, J.. Sci. 1997, 50, 324. 
 Gilbert, A. M., Failli ,A., Shumsky ,J., Yang Y., J. Med. Chem., 49, 6027 (2006). 
Gopalsamy ,A., Yang ,H., Ellingboe, J. W., Tsou, H.,(2005)  Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as 
novel anti-proliferative agents: parallel synthesis for lead optimization of amide region Bioorg. Med. 
Chem. Lett., 15, 1591 . 
Greenwood, D., Antimicrobial Chemotherapy, 4th ed, Oxford University press, New York, p. 114 (2000). 
Gursoy, S. A., Demirayak, G., Capan, K., (2000),Synthesis and preliminary evaluation of new 5-pyrazolinone 
derivatives asanalgesic agentsEur. J. Med. Chem., 35, 359 . 
Hilgard ,P., Thornes ,R. D., Eur. J. Cancer 1976, 12, 755. 
Jiang ,J. B., Hesson ,D. P., Dusak, B. A., Dexter, D. L., Kang ,G. J., Hamel ,E.(1990), Synthesis and biological 
evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit 
tubulin polymerization J. Med. Chem., 33, 1721 . 
Jolly ,C., Morimoto, R. I., J. Natl. Cancer Inst., 92, 1564 (2000). 
Janssen, A. M., Scheffer, J. J., Svendsen ,A. B.,  Planta Med. 53, 395 (1987). 
Jorgensen ,J. H., Jurnide, J. D.,(1999) Washington ,J. A., Washington, DC, USA, pp 1526 . 
Katiyar, S. B., Srivastava ,K., Purib ,S. K., P. M. S. Chauhana, (2005),Synthesis of 2-[3,5-substituted pyrazol-1-
yl]-4,6-trisubstitutedtriazine derivatives as antimalarial agents,Bioorg. Med. Chem. Lett., 15, 4957.  
Luque, F.J., Lopez, J.M., Orozco ,M.,(2000) Perspective on ``Electrostatic interactions of a solute with a 
continuum.A direct utilization of ab initio molecular potentials for the previsionof solvent effects, 
Theor. Chem. Acc. 103, 343–345. 
Mirjana P., Vesna K. , SasaSpaic, m. S., Gordana D,J. , LidijaA. , Velimir P.(2014), 2-Substituted thiazole-4-
carboxamide derivatives as tiazo furin mimics: synthesis and in vitro antitumour activity Tetrahedron 
70 (2014) 2343-2350. 
Moukha, O. Chafiq, Taha, M. L., Lazrek, H. B., Vasseur, J.-J., Farmaco, 57, 27 (2002.) 
Nauduri ,D., Reddy ,G. B., Chem. Pharm. Bull., 46, 1254 (1998). 
Okulik ,N., Jubert ,A.H., Internet electron, J. Mol. Des. 4 (2005) 17–30. 
Prasath ,R. , Bhavana, P. , Sarveswari ,S. , SeikWeng Ng , Edward R.T. Tiekink , (2015),Efficient ultrasound-
assisted synthesis, spectroscopic, crystallographic and biological investigations of pyrazole-appended 
quinolinyl chalcones Journal of Molecular Structure 1081 ,201–210. 
Parlok, J. J., J. Heterocycl. Chem., 35, 1493 (1998). 
Rathelot, P., Azas N., H. El-Kashef, Delmas ,F., Eur. J. Med. Chem., 37, 671 (2002). 
Rebecca R. Midtkandal , Philip Redpath , Samuel A. J. Trammell, Simon J. F. (2012) 5204–5207. 
Rav, P.,(2015 ),Experimental and DFT studies on the structure, infrared and Raman 
spectral properties of dinitro pyrazoles , Journal of Molecular Structure ,1079 433–447. 
Scrocco, E., Tomasi, J., Adv. Quantum Chem. 11 (1978) 115–121. 
Schallner ,O., Heinz ,K. H., K., Karl ,Ger. Offen DE19615259 (1997) (Chem. Abstr., 127, 346387 (1997). 
Shuduan Deng, Xianghong Li,(2012) Inhibition by Ginkgo leaves extract of the corrosion of steel in HCl and 
H2SO4 solutions 
Corros. Sci. 55 ,407–415. 
Tsuji ,K., Nakamurana ,K., Konishi, N., Tojo ,T., Ochi, T., Scnoh, H., Masuo ,M., Chem. Pharm. Bull., 45, 987 
(1997). 
Tsurumi, K., A. Abe, Fujimura ,H., Asai ,H., et al., Folia Pharmacol.Jpn. 72, 41 (1976). 
Wise, L. D., Butler ,D. E., Dewald ,H. A., Lustgarten, D. M., Pattison I. C., D. N. Schweiss, Coughenour ,L. L., 
Downs, D. A., Heffner ,T. G., Pugsley, T. A., J. Med. Chem., 30, 1807 (1987). 
Ya-Juan Qin,Peng-Fei Wang,Jigar A. Makawana, Zhong-Chang Wang,Ze-Nan Wang, Yan-Gu, Ai-Qin 
Jiang , Hai-Liang Zhu,( 2014),Design, synthesis and biological evaluation of metronidazole–thiazole 
derivatives as antibacterial inhibitors, Bioorganic & Medicinal Chemistry Letters, 24 ,5279–5283 
 
Chemistry and Materials Research                                                                                                                                                    www.iiste.org 
ISSN 2224- 3224 (Print) ISSN 2225- 0956 (Online) 
Vol.6 No.12, 2014 
 
51 
Tables 
Table I. Minimum inhibitory concentration (MIC in µg/mL) of the title compounds. The negative control 
DMSO showed no activity. 
  
Compound             Bacillus subtilisPseudomonas    Streptomyces 
 aeruginosa species 
                              (Gram-positive)            (Gram-negative)       (Actinomycetes) 
 
I                                      75                                  100                               75 
II                                     75                                    75                                 125 
III                                    75                                    75                                  75 
IV                                     75                                   100                                75 
Penicillin              31                                    46                                  33 
 
t
otally inactive (MIC >500 µg/mL). 
 
Table 2: Quantum chemical parameters of the investigated compounds. 
Compound EHOMO(eV) ELUMO(eV) ∆E(eV) µ(debye) LogP 
I -6.01 0.430 6.47 1.87 7.03 
II -6.00 0.327 6.32 4.03 6.27 
III -5.528 0.06 5.58 3.87 5.79 
IV -6.111 0.36 6.41 7.86 6.89 
 
 
 
n= 3-( D-oxylopentitolyl)            
Scheme 1 
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Figures 
 
Fig. 1 :The antimicrobial activity of the synthesized compounds evaluated against three microorganisms; 
Bacillus subtilis, Pseudomonas aeruginosa and Streptomyces species.  
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Fig. 2: The frontier molecule orbital density distributions of compound I,II, III, and IV 
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Fig.3:Molecular electrostatic potential map of the compounds 
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